Foundry Partners, LLC Collegium Pharmaceutical, Inc Transaction History
Foundry Partners, LLC
- $1.82 Billion
- Q1 2025
A detailed history of Foundry Partners, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Foundry Partners, LLC holds 16,170 shares of COLL stock, worth $507,091. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,170
Previous 16,162
0.05%
Holding current value
$507,091
Previous $463,000
4.1%
% of portfolio
0.03%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
37.1MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$182 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$94.1 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$82.8 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$70.5 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$51.2 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.07B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...